CoreCap Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
600
+57
+10% +$21.1K 0.01% 812
2026
Q1
$159K Sell
543
-14
-3% -$4.6K 0.01% 873
2025
Q4
$195K Buy
557
+32
+6% +$10.8K 0.01% 803
2025
Q3
$170K Buy
525
+59
+13% +$18.4K 0.01% 851
2025
Q2
$181K Buy
466
+122
+35% +$49.1K 0.01% 771
2025
Q1
$150K Buy
344
+13
+4% +$5.22K 0.01% 760
2024
Q4
$122K Buy
331
+246
+289% +$103K 0.01% 861
2024
Q3
$44.2K Buy
+85
New +$45.4K ﹤0.01% 1238
2024
Q2
Sell
-56
Closed -$29K 1881
2024
Q1
$29K Buy
+56
New +$27.9K ﹤0.01% 1321
2022
Q4
$80.5K Buy
+157
New +$79.7K 0.01% 814
2022
Q3
Sell
-105
Closed -$51K 965
2022
Q2
$51K Buy
+105
New +$51.9K ﹤0.01% 931
2022
Q1
Sell
-311
Closed -$144K 975
2021
Q4
$144K Buy
+311
New +$131K 0.01% 625

Other funds holding ELV

CoreCap Advisors's ELV Position: Q2 2026 in Review

CoreCap Advisors increased its Elevance Health (ELV) stake by 10% in Q2 2026, buying an estimated $21.1K and bringing the position to 600 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #812.

CoreCap Advisors first reported a position in ELV in Q4 2021 and has held it in 12 quarters since. 413 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • CoreCap Advisors held 600 shares of Elevance Health worth $232K as of Q2 2026.
  • CoreCap Advisors bought 57 Elevance Health shares in Q2 2026, an estimated $21.1K.
  • Elevance Health made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #812 holding.
  • CoreCap Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 12 quarters since.
  • 413 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.